{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:23:37Z","timestamp":1783531417618,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012913","name":"Tata Consultancy Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012913","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejogrb.2025.114637","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T23:12:08Z","timestamp":1754521928000},"page":"114637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Efficacy and safety of ebopiprant to delay preterm birth after oral administration in pregnant women with spontaneous preterm labor receiving atosiban: a phase 2a, double-blind, parallel group, randomized, placebo-controlled, proof of concept study"],"prefix":"10.1016","volume":"313","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-550X","authenticated-orcid":false,"given":"B.W.","family":"Mol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Fatkullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Islamova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Parizek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Janku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Biron-Shental","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Humberstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Brethous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ejogrb.2025.114637_b0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1742-4755-10-S1-S1","article-title":"Born too soon: preterm birth matters","volume":"10","author":"Howson","year":"2013","journal-title":"Reprod Health"},{"key":"10.1016\/j.ejogrb.2025.114637_b0010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(14)61698-6","article-title":"Global, regional, and national causes of child mortality in 2000\u201313, with projections to inform post-2015 priorities: an updated systematic analysis","volume":"385","author":"Liu","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2025.114637_b0015","first-page":"1","article-title":"Infant mortality statistics from the 2013 period linked birth\/infant death data set","volume":"64","author":"Matthews","year":"2015","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ejogrb.2025.114637_b0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-3782(98)00052-8","article-title":"Outcomes of children of extremely low birthweight and gestational age in the 1990's","volume":"53","author":"Hack","year":"1999","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ejogrb.2025.114637_b0025","doi-asserted-by":"crossref","first-page":"e7961","DOI":"10.1136\/bmj.e7961","article-title":"Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies","volume":"345","author":"Moore","year":"2012","journal-title":"BMJ"},{"issue":"9859","key":"10.1016\/j.ejogrb.2025.114637_b0030","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2025.114637_b0035","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"3","author":"Roberts","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2025.114637_b0040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0b013e318199924a","article-title":"Tocolytic therapy: a meta-analysis and decision analysis","volume":"113","author":"Haas","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.114637_b0045","doi-asserted-by":"crossref","first-page":"e6226","DOI":"10.1136\/bmj.e6226","article-title":"Tocolytic therapy for preterm delivery: systematic review and network meta-analysis","volume":"345","author":"Haas","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2025.114637_b0050","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0140-6736(16)00548-1","article-title":"Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial","volume":"387","author":"van Vliet","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2025.114637_b0055","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/bcp.13622","article-title":"Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2alpha receptor antagonist tocolytic: a first-in-human trial in healthy postmenopausal women","volume":"84","author":"Pohl","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejogrb.2025.114637_b0060","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/bcp.13925","article-title":"Co-administration of the prostaglandin F2alpha receptor antagonist pre-term labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasone","volume":"85","author":"Pohl","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"c332","key":"10.1016\/j.ejogrb.2025.114637_b0065","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2025.114637_b0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/tog.12460","article-title":"Spontaneous preterm birth prevention in multiple pregnancy","volume":"20","author":"Murray","year":"2018","journal-title":"Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2025.114637_b0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/1471-0528.14151","article-title":"The pregnant women as a drug orphan: a global survey of registered clinical trials of pharmacological interventions in pregnancy","volume":"124","author":"Scaffidi","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2025.114637_b0080","article-title":"Tocolytics for delaying preterm birth: a network meta-analysis (0924)","volume":"8","author":"Wilson","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2025.114637_b0085","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(25)00295-8","article-title":"8 Study Group. Atosiban versus placebo for threatened preterm birth (APOSTEL 8): a multicentre, randomised controlled trial","volume":"405","author":"van der Windt","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2025.114637_b0090","article-title":"Oxytocin receptor antagonists for inhibiting preterm labour","volume":"6","author":"Flenady","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525009133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525009133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:27:58Z","timestamp":1770985678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525009133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":18,"alternative-id":["S0301211525009133"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114637","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of ebopiprant to delay preterm birth after oral administration in pregnant women with spontaneous preterm labor receiving atosiban: a phase 2a, double-blind, parallel group, randomized, placebo-controlled, proof of concept study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114637"}}